PeerView

Combat challenges in frontline #CLL care! Learn how time-limited BTK-BCL2i regimens are reshaping treatment options for treatment-naive patients. Watch this CME/EBAH #PeerView expert seminar based on #PeerView events at the #18ICML and #EHA2025! bit.ly/4eDDdn3

A global #CLL patient survey, the latest from #EHA2025, and expert commentary on BTKi & BCL2i. Experts Dr. Toby A. Eyre (@tobyeyre82 ), and Jennifer Woyach, MD, give insights on sequential care. @CLLSociety bit.ly/41fVfIr

Exciting progress in treating neuroendocrine tumors (#NET) and #pancreaticcancer! Watch this Seminars and Tumor Board activity to explore the latest clinical data and treatment strategies. @Ahn_Daniel_Onc @letswinpc @netcanceraware bit.ly/44yk0RM

Are you prepared to bring modern #RCC care to your patients across disease stages and histologic subtypes? Get guidance from Drs. Pal (@montypal), McDermott (@uromigos), & Zhang (@tiansterzhang). Produced with @KCCure. bit.ly/4ntmIQ4 #ASCO25 #MedEd

Exciting advancements in #GastricCancer treatment! From immune checkpoint inhibitors to novel subcutaneous forms and targeted therapies, dive into groundbreaking clinical trials with our newest activity! bit.ly/4luamFG @StoCANcer

From frontline to R/R B-ALL, bispecific T-cell engagers are transforming #ALL care! Join leading experts, Elias Jabbour, MD, and Ibrahim Aldoss, MD, as they explore the latest evidence and review real-world cases. #HemOnc #MedEd bit.ly/4foTTjm

Check out the online version of our live event “Delivering Innovative, Personalized Care From Newly Diagnosed to Relapsed #MultipleMyeloma” with Sagar Lonial, MD, FACP. Produced with @HealthTree. bit.ly/44mk3Py #ASCO25 #hematology #oncology

What are experts @NitinJainMD, @KrishPatelMD, & @MCThompsonMD saying about sequencing BTKi & BCL2i in CLL & the future of care with next-gen agents? Find out in our new @PeerView TownHall, recorded at #ASCO25 & featuring CLL Society. Watch now! bit.ly/3TiuzlO

The number of effective #ProstateCancer treatments continues to expand. Drs. Fizazi, Castro (@ecastromarcos), & Smith provide the guidance you need to ensure that patients at all stages benefit from these innovations. Produced with @ZEROcancer. bit.ly/44hhK05 #ASCO25

Does your #EmergencyDepartment have protocols for recognizing and managing amyloid-related imaging abnormalities (ARIA)? Hear expert insights on how to overcome challenges associated with ARIA in the ED and establish a framework for effective care bit.ly/4hpvXgo

BTC care is a team effort. Sharpen your clinical decision-making with insights from the #Cholangiocarcinoma MasterClass & Practicum, in collaboration with @curecc. Featuring Drs. Vogel, Harding & Macarulla. 👉 bit.ly/3Gfs5l8

Looking for the latest data on #GastricCancer & #EsophagealCancer care? Drs Samuel Cytryn (@Sam_Cytryn) & Yelena Y Janjigian (@YJanjigianMD) recently met to discuss treatment options in resectable disease. Click to watch! bit.ly/4mpyryt #StomachCancer #Oncology #MedEd

How are #sarcoma clinicians integrating gamma-secretase inhibitors into tx for #DesmoidTumor? Prof Dr Patrick Schöffski @schoffski & Dr Breelyn A Wilky @breelynwilkyMD discussed during #SARCtrials Semi-Annual Meeting: bit.ly/43YODj8 #oncology @DTRFoundation @SARCtrials

“Advancing #CLL Care: Integrating Standards of Care and Next-Gen Innovation.” Review the latest evidence and guidelines with William G. Wierda, MD, PhD (@wwierda), John N. Allan, MD, & Nicole Lamanna, MD, at #SOHO2025. 9/4 at 7:52 PM CDT. bit.ly/CLLHouston25T #hematology

Thank you to @jayCDoesID, and @JewelMMullen for an insightful discussion at our #RSV symposium! Your expertise brought real-world impact to this conversation. 📺 Missed it? Catch the virtual symposium on July 31st: bit.ly/2025RSVT #CME #MedEd

Precision Matters in NSCLC: Tune in now to get expert insight on designing personalized care plans using optimally targeted regimens for patients with #NSCLC. Recorded at #ASCO2025. Produced with @Lungevity @OncBrothers @glopesMD bit.ly/44mEaNm #Oncology #MedEd #PeerView

Learn to apply modern #Immunotherapy strategies across the #NSCLC continuum with Drs. Cascone, Wakelee (@HwakeleeMD), Brahmer (@JulieBrahmer), and Schoenfeld (@AdamJSchoenfeld) in this #PeerView session, presented in partnership with @Lungevity. bit.ly/4iI7wvE #ASCO25

Explore real-world cases and insights on immunotherapy in unresectable & resectable #Melanoma in this #MedEd activity from #ASCO2025, featuring Dr. Hussein Tawbi, Prof. Paolo Antonio Ascierto, & @GlitzaMDPhD, with @AIMatMelanoma and AIM with Immunotherapy bit.ly/3TclQkY

Implementing #ImmunoOncology in #GynecologicCancer care for #Veterans: Elevate your practice with expert insights on the latest data! 8/22 at 2:00 PM EDT. Produced with @navref. bit.ly/IOGyn25T #PeerView #Oncology

Recognizing ARIA in the #EmergencyDepartment is crucial! Learn about amyloid-targeting therapies and the risk factors associated with ARIA. Early detection can make all the difference! bit.ly/4hpvXgo